What makes peptides powerful is their precision
Nutrition, sun protection, and healthy habits remain fundamental
Timing: Bedtime administration leverages natural nocturnal GH pulse
Key Safety Differentiators No IGF-1 elevation: AOD-9604 does not stimulate IGF-1, meaning it avoids risks such as organ/tissue overgrowth or acromegaly No glucose disruption: Clinical data shows it does not impair insulin sensitivity or worsen blood sugar regulation Comparable to placebo: In obesity trials, the incidence of adverse effects was similar to placebo groups, underscoring its tolerability Legal Status of AOD-9604 United States: AOD-9604 is not FDA-approved as a drug, dietary supplement, or weight loss therapy
A Food and Drug Administration advisory panel last week recommended loosening compounding restrictions for six out of seven peptides it reviewed, despite safety and efficacy concerns expressed by agency scientists
WHAT ARE LIPOPLEX INJECTIONS